Ross L - Search Results

1

Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults.

McMahon D, Lederman M, Haas DW, Haubrich R, Stanford J, Cooney E, Horton J, Kelleher D, Ross L, Cutrell A, Lee D, Spreen W, Mellors JW. McMahon D, et al. Among authors: ross l. Antivir Ther. 2001 Jun;6(2):105-14. Antivir Ther. 2001. PMID: 11491415 Clinical Trial.

2

Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.

Gallant JE, Rodriguez AE, Weinberg WG, Young B, Berger DS, Lim ML, Liao Q, Ross L, Johnson J, Shaefer MS; ESS30009 Study. Gallant JE, et al. Among authors: ross l. J Infect Dis. 2005 Dec 1;192(11):1921-30. doi: 10.1086/498069. Epub 2005 Oct 25. J Infect Dis. 2005. PMID: 16267763 Clinical Trial.

3

Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations.

Hsu R, Lanier ER, Rouse EG, Oie KL, Pappa KA, Ross LL. Hsu R, et al. Among authors: ross ll. Antivir Ther. 2008;13(5):735-7. Antivir Ther. 2008. PMID: 18771059

4

Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir.

Ross LL, Rouse E, Gerondelis P, DeJesus E, Cohen C, Horton J, Ha B, Lanier ER, Elion R; COL40263 study. Ross LL, et al. J Antimicrob Chemother. 2010 Feb;65(2):307-15. doi: 10.1093/jac/dkp419. Epub 2009 Dec 15. J Antimicrob Chemother. 2010. PMID: 20008905 Free PMC article.

5

Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients.

Ross LL, Weinberg WG, DeJesus E, Fischl MA, Horton JH, Pappa KA, Lancaster CT, Pakes GE, Smith KY. Ross LL, et al. AIDS Res Hum Retroviruses. 2010 Apr;26(4):407-17. doi: 10.1089/aid.2009.0189. AIDS Res Hum Retroviruses. 2010. PMID: 20380480 Free PMC article. Clinical Trial.

6

Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing.

D'Aquila RT, Geretti AM, Horton JH, Rouse E, Kheshti A, Raffanti S, Oie K, Pappa K, Ross LL. D'Aquila RT, et al. Among authors: ross ll. AIDS Res Hum Retroviruses. 2011 Feb;27(2):201-9. doi: 10.1089/aid.2010.0077. Epub 2010 Oct 7. AIDS Res Hum Retroviruses. 2011. PMID: 20929395

7

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

Ross LL, Walker AS, Lou Y, Tenorio AR, Gibb DM, Double J, Gilks C, McCoig CC, Munderi P, Musoro G, Kityo CM, Grosskurth H, Hakim J, Mugyenyi PN, Cutrell A, Perger T, Shaefer MS. Ross LL, et al. PLoS One. 2019 Nov 14;14(11):e0225199. doi: 10.1371/journal.pone.0225199. eCollection 2019. PLoS One. 2019. PMID: 31725787 Free PMC article.

8

Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.

Scarsella A, Coodley G, Shalit P, Anderson R, Fisher RL, Liao Q, Ross LL, Hernandez JE. Scarsella A, et al. Among authors: ross ll. Adv Ther. 2002 Jan-Feb;19(1):1-8. doi: 10.1007/BF02850013. Adv Ther. 2002. PMID: 12008857

9

Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.

Cherry CL, Lal L, Thompson KA, McLean CA, Ross LL, Hernandez J, Wesselingh SL, McComsey G. Cherry CL, et al. Among authors: ross ll. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):263-7. J Acquir Immune Defic Syndr. 2005. PMID: 15735442

10

Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.

Hicks CB, DeJesus E, Sloan LM, Sension MG, Wohl DA, Liao Q, Ross LL, Pakes GE, Pappa KA, Lancaster CT; COL100758 Study Team. Hicks CB, et al. Among authors: ross ll. AIDS Res Hum Retroviruses. 2009 Apr;25(4):395-403. doi: 10.1089/aid.2008.0231. AIDS Res Hum Retroviruses. 2009. PMID: 19320570 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,051 results

Search Page

Filters